<DOC>
	<DOCNO>NCT02081989</DOCNO>
	<brief_summary>Renal denervation ( use radio wave oblate renal artery ) show effective treatment high blood pressure . It currently test heart failure patient would like look effect diabetes . We therefore plan enrol 20 participant type II diabetes study . Half undergo renal denervation addition standard care half act control receive standard care . Treatment allocation randomly assign . All participant undergo screen ( include physical exam , blood test , ultrasound muscle biopsy ) . All patient follow test ( include physical exam blood test ) 1 , 3 6 month later .</brief_summary>
	<brief_title>Renal Denervation Diabetes .</brief_title>
	<detailed_description />
	<criteria>Over 18 year Able willing provide inform consent Patients establish type II diabetes mellitus ( HbA1C &gt; 7 % , diet oral hypoglycaemic agent ) Clinical stable demonstrate change background antidiabetic medication last 30 day . Anticipated patient able maintain stable dose medication duration study Renal arterial anatomy ineligible RDN : main renal artery &lt; 4 mm diameter &lt; 20 mm treatable length ; multiple renal artery main renal artery estimate supply &lt; 75 % kidney ; haemodynamically anatomically significant renal artery abnormality stenosis either renal artery , investigator 's opinion , would interfere safe cannulation renal artery require surgical repair interventional dilation History prior renal artery intervention include balloon angioplasty , stenting previous renal denervation . Single function kidney Need insulin ( interfere euglycemic clamp test ) GLPI analogues eGFR &lt; 30 ml/min ( MDRD formula ) Any medical condition , investigator opinion , may adversely affect participant safety trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Renal denervation</keyword>
</DOC>